Company Filing History:
Years Active: 2021
Title: Christopher Laumer: Innovator in Genomic Sequencing
Introduction
Christopher Laumer is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of genomic research, particularly through his innovative patent in duplex sequencing technology. His work is essential for advancing our understanding of genetic information.
Latest Patents
Laumer holds a patent titled "Duplex sequencing using direct repeat molecules." This patent describes a population of direct repeat molecules, where each molecule contains a direct repeat composed of sequences amplified from the opposite strands of a double-stranded fragment of genomic DNA. The first repeat, referred to as TOP, is amplified from one strand, while the second repeat, known as BOT, is amplified from the other strand of the same fragment. This innovative approach enhances the accuracy and efficiency of genomic sequencing.
Career Highlights
Christopher Laumer is currently employed at Genome Research Limited, where he continues to push the boundaries of genomic research. His work at this esteemed institution has positioned him as a key player in the field of genetics and molecular biology. Laumer's dedication to innovation is evident in his research and development efforts.
Collaborations
Throughout his career, Laumer has collaborated with various professionals in the field, including his coworker Robert Osborne. These collaborations have fostered a dynamic environment for research and innovation, allowing for the exchange of ideas and expertise that drive advancements in genomic technologies.